Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)
Public ClinicalTrials.gov record NCT05089084. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome
Study identification
- NCT ID
- NCT05089084
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Arrowhead Pharmaceuticals
- Industry
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Plozasiran Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 13, 2021
- Primary completion
- Apr 28, 2024
- Completion
- Mar 31, 2026
- Last update posted
- Feb 3, 2026
2021 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site 1 | Boca Raton | Florida | 33434 | — |
| Clinical Site 2 | Suwanee | Georgia | 30024 | — |
| Clinical Site 3 | Indianapolis | Indiana | 46290 | — |
| Clinical Site 4 | Elkridge | Maryland | 21075 | — |
| Clinical Site 5 | St Louis | Missouri | 63110 | — |
| Clinical Site 7 | New York | New York | 10016 | — |
| Clinical Site 6 | New York | New York | 10029 | — |
| Clinical Site 8 | Austin | Texas | 78731 | — |
| Clinical Site 9 | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05089084, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05089084 live on ClinicalTrials.gov.